Skip to main content

Psychological adjustment of men with prostate cancer: a review of the literature



Prostate cancer (PCA) is the most common malignancy and a major cause of death in men but, importantly, a substantial proportion will live for several years following diagnosis. However, they face the prospect of experiencing symptoms, side-effects of treatment and diminished quality of life. The patient's psychological adjustment is particularly complex, given the potential trajectory of the disease, from the point of diagnosis, with its immediate impact, to the phase of palliative care, with its attendant issue of facing mortality. Since a comprehensive review of the literature on psychological adjustment of men with PCA has not yet been done, we have documented relevant research, integrated findings and drawn conclusions, where possible, in order to map out clinical and research implications.


We searched 5 databases for the period 1994 – July 2006, during which most of the work in the field has been done.


We found few studies of substance among the 60 we examined to draw conclusions about psychological adjustment to prostate cancer and its treatment. This is in marked contrast to the picture in breast cancer. While some patterns have emerged, many gaps remain to be filled.


Aspects of methodology need attention, particularly longitudinal, prospective designs, incorporation of control groups and the use of valid and reliable measures. There is scope for qualitative studies as a complement to quantitative research.


Prostate cancer (PCA) is the most common malignancy and a major cause of death in men but, importantly, most patients will live for a decade or longer following diagnosis. Consequently, they face the prospect of experiencing symptoms, side-effects of treatment, and diminished quality of life [1]. Research on psychological adjustment to PCA suggests that it is related to factors such as the stage of the cancer, time since diagnosis, and type of treatment given. The latter is especially noteworthy, given the range of interventions, which include watchful waiting, radiation treatment (external beam and brachytherapy), surgery and hormonal therapy.

Puzzlingly, almost all research has been devoted to physical aspects and side-effects of treatment and very little to such psychological features as emotional distress, coping and psychiatric morbidity. Psychological adjustment is complex, given the disease's potential trajectory – from the point of diagnosis, with its immediate impact, to the phase of palliative care, with its attendant existential issues. Since a focused review of the literature on psychological adjustment has not yet been published, we have documented what is known about this important aspect, integrated pertinent findings and drawn conclusions, where possible, in order to map out clinical and future research implications.

In doing so, we extend the contribution of Eton and Lepore [2], who reviewed studies on health-related quality of life, both PCA-specific and general. They mainly paid attention to physical aspects (urinary, sexual and bowel) but psychosocial associations were also addressed. They confined their coverage to three types of studies: cross-sectional, longitudinal and those incorporating a comparison group. We have taken a different approach by concentrating on psychological adjustment specifically but refer when necessary to the physical domain. Kiss and Meryn [3] have compared psychosocial aspects of PCA and breast cancer but cited only a small proportion of the studies published. Roesch et al. [4] have conducted a meta-analytic review of coping with PCA, to which we refer below.


We searched five databases: Medline, PsycINFO, Biological Abstracts, Sociological Abstracts and Cumulative Index to Nursing and Allied Health (CINAHL), for the period 1994 – July 2006, during which period most of the research had been done. Given the lack of a review on the ways in which men with PCA deal with psychological aspects of the experience, we opted to focus on the most pertinent aspects of psychological and psychiatric morbidity, coping and adjustment, and the potential effects of psychosocial (interventions to assist patients to manage effectively) used combinations of the following terms: prostate cancer, psychological adjustment, psychiatric, psychosocial, morbidity, distress, depression, anxiety, coping, and quality of life (QOL). A manualized search of relevant references cited in the identified articles followed. Given the brief history of systematic research, we opted to be inclusive but only incorporated studies with reasonably sized and unbiased samples and appropriate designs, including adequate descriptions of instruments used. Thus, we have excluded, for instance, case histories and anecdotal reports. We also omitted the small number of non-English articles, research on couple and family aspects (the subject of a separate review in press), and studies that combined two or more cancer groups where it was impossible to comment on the PCA subgroup separately. We examined unpublished dissertations but did not find any of notably original substance; it is conceivable that, if any of this work reaches peer-reviewed publication, it will then warrant attention of future reviewers.

We identified 60 reports, covering a range of topics. In order to evaluate the material systematically, we partitioned it into five coherent categories: cross-sectional, longitudinal, coping, PCA treatments and their psychological effects and the impact of psychological interventions. Given the constraints of space, we have created 8 tables which contain the main elements of the studies we necessarily have had to consider schematically in the text. After addressing each in turn, we have concluded with a critique of the overall endeavour and a discussion of clinical and research implications. We had entertained conducting a meta-analysis of intervention studies but concluded this was unwarranted in that there were very few controlled trials, and almost all of them were relatively unsophisticated conceptually.

Cross-sectional studies of psychological adjustment to PCA (see Table 1)

Table 1 Cross-sectional studies of psychological adjustment to prostate cancer

Studies by Bacon et al. [5], Clark et al. [6] and Helgason et al. [7] stand out since the samples are adequate and compared with controls. The Helgason team reported diminished sexual function for both but that a greater proportion of the men with PCA were 'severely distressed' by this. Both Clark's and Bacon's groups found patients more bothered than controls by bowel, urinary and sexual symptoms, but mental health scores were similar in the two groups in Bacon et al. In essence, although affected by symptoms, patients did not report more distress than did healthy men. Clark et al. found that psychological adjustment was as affected as physical status. Questionnaires developed for the latter study revealed greater complexity than had previously been discerned. For example, certain treatments were associated with patients' confidence that the cancer was under control although they still felt a loss of intimacy and masculinity.

Three papers have concentrated on depressive symptoms. Heim and Oei [8] found one in five patients reporting depression, half of these at the 'severe' level. Depression correlated strongly with ratings of pain. The vaguely described sample of convenience (80% labelled 'non-metastatic') is a distinct limitation. Stone et al. [9] observed severe levels of fatigue related to depression, especially in men with advanced disease. Although the study included controls, the sample was small, precluding generalisation of the finding. Balderson and Towell [10] assessed, retrospectively, 94 men at various stages of PCA. Distress, as reflected in mixed depression and anxiety in 38% of them, was associated with poorer social, physical and functional well-being. As this was a sample of patients seeking support, it is difficult to generalise the findings.

Researchers have tended to view PCA patients as a homogeneous group but subgroups, for example men with localised early-stage disease (often asymptomatic) and metastatic disease (usually linked to recurrence), are identifiable. Different psychological reactions can be anticipated. Curran et al. [11], for instance, compared men with localised, metastatic and hormone-resistant cancer. Those with localised disease had better adjustment than the advanced groups.

Patients with long-standing PCA grapple with several psychological challenges. Schag et al. [12] studied this in a convenience sample diagnosed five or more years earlier. The men, particularly those with a co morbid physical or psychiatric disorder, reported a decline in psychological functioning, with escalating distress and cognitive impairment.

McBride et al. [13] examined the psychological effects of a cancer diagnosis using the Impact of Events Scale [14]. Strengths included the large sample of 420 men, most of whom underwent surgery. A briefer period since diagnosis and regular exercise were both related to lower levels of psychological distress. Penedo et al. [15] examined the relationship between perceived stress management skills, optimism and positive mood in 46 men who had undergone radical prostatectomy for localised PCA. While optimism was, not surprisingly, associated with positive mood, the relationship was mediated by the self-reported skills in stress management. The results support a focus on promoting strategies to deal with stress in any psychosocial intervention.

Few of the above investigations have enlisted large samples or controls, although we have noted three exceptions [57]. Nonetheless, we can state that PCA patients, examined at a single point, experience poor psychological adjustment in relation to specific symptoms, particularly sexual, bowel, pain and fatigue. They also exhibit psychological reactions not easily detected by broad measures. The question as to whether associations are a function of stage of disease, type of treatment or other factors remains unanswered. Data comparing distress between clinical subgroups are scanty [11].

Longitudinal studies of psychological adjustment to PCA (see Table 2)

Table 2 Longitudinal studies of psychological adjustment to prostate cancer

The demands of a longitudinal design have presumably militated against investigators tackling psychological adjustment over time as such studies are rare. We have identified a mere two, compared to the nine aforementioned cross-sectional studies. Nordin et al. [16] investigated depression and anxiety over six months following diagnosis. Levels of depression and anxiety at time of diagnosis were lower in the PCA than other cancer groups but were strong predictors of levels six months later, that is, those initially depressed or anxious remained so at follow up. Less social support outside the family and advanced disease at baseline also predicted depression and anxiety.

Visser et al. [17] examined QOL for three months following a PCA diagnosis and compared them with those of men diagnosed with benign prostatic hyperplasia (BPH). Only the cancer patients experienced reduced QOL. Importantly, the effect resulted from changed physical functioning; psychological factors contributed only marginally.

Longitudinal designs allow researchers to track the course of psychological adjustment but only one unreplicated finding emerges from the scanty above work – levels of depression and anxiety at the time of diagnosis identify those likely to be feeling depressed or anxious at follow-up. Screening and corresponding early intervention may therefore reduce longer-term psychological ill-effects but this ideal remains to be tested.

Patterns of coping (see Table 3)

Table 3 Coping in men with prostate cancer

We found a relatively small number of 'acceptable' papers on coping, which is surprising given how relevant this topic is for psychological adjustment. Roesch et al., (2005), in their meta-analysis, included a greater number of studies, some of which did not meet our inclusion criteria. Their conclusions were that active, as opposed to more avoidant, approaches to coping with PCS are most beneficial for adjustment. Our review of this topic supports these conclusions.

Helgeson and Lepore [18] investigated the role that self-concept played in physical and emotional functioning. Men who focused on themselves, compared to those more interpersonally involved, had difficulty expressing emotions, which in turn could have mediated adjustment to their cancer.

The same group [19] examined men with PCA, diagnosed an average 17 months earlier. Those who were psychologically distressed found it difficult to talk about their condition with anyone. The authors speculated that support networks might reduce distress by allowing men to "process" their experience (a model familiar to those working in the trauma area). While these results are of interest, only prospective studies can illuminate the subject further.

Zakowski et al. [20] have provided an intriguing analysis of sex differences in emotional expression in cancer patients. While the results are limited by sample size [41 women with breast cancer and 41 men with PCA) and their inferences speculative, the findings warrant consideration. Expected differences between the men and women in terms of self-reported emotional expression as a means of coping emerged but these were not significant. However, the men reported that their spouses/partners were likely to be their main source of support whereas women had additional sources. Consequently, if men reported constraints on emotional expression they were likely to feel more distressed. Presumably, this was because women had more opportunities to express themselves, a strategy promoting adjustment. The possibility, that encouraging men's communication with their spouses, and beyond, could improve adjustment, is a promising one.

A common feature of coping research is to apply a standardised coping measure. A popular choice is the Mental Adjustment to Cancer (MAC) scale [21]. Bjork et al. [22] have used this, together with other measures, to investigate adjustment of men with PCA. With a small sample, and wide variation in the time between diagnosis and participation, validity is in doubt; results, however, are worth recounting. Helplessness was related to lowered self-esteem, appraisal of loss to depression, appraisal of threat to anxiety, and optimism, inversely, to depression and anxiety.

Results from these, and from other studies we excluded because of methodological limitations, have been integrated in a comprehensive meta-analysis [4]. Approach-type (problem-focused and emotion-focused) coping are associated with more positive psychological adjustment as well as better physical health in men with PCA. By contrast, avoidance-type strategies are linked to poor psychological adjustment and physical health. The evidence supports encouraging approach-type coping in any potential intervention.

Despite drawing this implication, potential research limitations must be borne in mind. Radically different ways of conceptualising coping have been adopted, using retrospective, cross-sectional designs. Researchers need to adopt a theory-based, prospective approach to study the relationship between coping and adjustment if the conclusions by Roesch et al. are to be confirmed.

Treatments for PCA and psychological adjustment

Consensus has not been achieved as to indications of treatments in PCA. Moreover, decision-making is influenced by patients' attitudes to side-effects. As a corollary, adjustment assumes greater relevance. If a treatment is associated with side-effects such as fatigue and depression, overall psychological adjustment may deteriorate. Research on links between treatment and adjustment is clearly relevant. What follows is an account of this work, starting with surgery.

Radical prostatectomy (RP) and psychological adjustment (see Table 4)

Table 4 Radical prostatectomy (RP) and psychological adjustment

In the most impressive of seven studies found, involving 500 men [23], 70% completed questionnaires an average three years after surgery (no measures were taken at baseline). The mental health of those who did and did not experience recurrence was compared. Mental health was similar in the two groups, with overall satisfaction high. Thus, regardless of recurrence, men seem well adjusted, years after surgery.

In both an Italian survey of 161 men [21] and an Australian sample of 140 men [25], respondents mostly indicated minimal adverse effects in adjustment. Overall satisfaction was high. Sexual difficulties did not affect psychological functioning, suggesting that pursuit of cure outweighed sexual concerns.

British researchers [26], recognising that most erectile dysfunction questionnaires neglect psychological aspects, developed and validated a 15-item questionnaire, the Erectile Dysfunction Effect on QOL (ED-EQOL). They demonstrated retrospectively that surgery had a negative effect because of both direct physical factors and psychological influences. This study highlights the importance of using probing questionnaires to uncover subtle effects, rather than relying on diffuse survey tools.

Another Italian project [27] is less useful in that the sample was small. However, a control group undergoing surgery for benign prostatic hyperplasia was included. The PCA group had higher anxiety levels an average two years after surgery.

Rondorf-Klym and Colling [29] examined psychological adjustment 12 to 24 months after surgery. Perceived social support, self-esteem and locus of control all contributed to adjustment whereas age, sexual function and its appraisal, suppression of anger and depression did not.

The above studies suffer from two main limitations – follow-up ranging from one month to 15 years and psychological status, mostly assessed at a single point. Adjustment after surgery is tantamount to a journey – what patients encounter initially will differ from their experience at later points. Studies of adjustment over time are required, with distinctions made between immediate, intermediate and long-term stages.

Radiotherapy (RT) and psychological adjustment (See Table 5)

Table 5 Radiotherapy (RT) and psychological adjustment

The five identified reports are uninformative. Considering the role of radiotherapy in PCA, this is surprising. An Italian study [30] is typical: 118 patients treated over a 13-year period were invited to participate. Of these, 28 refused, and 20 were ineligible. The outcome measure was ad hoc, comprising prostate-based items 'taken from different sources'. Follow-up ranged from months to years. Thus, assessment occurred in the initial stage of therapy or years later.

Given that brachytherapy (BT) is a recent development, its association with psychological functioning has barely been examined. French investigators [31] focused on the association between combined BT and external beam RT, and adjustment. In a rare design, controls were derived from electoral rolls. Men with localised PCA completed the questionnaires at one point, four to eight years after treatment. All scores were similar to those of controls, suggesting that patients are not adversely affected by RT/BT despite many experiencing loss of libido, decreased sexual activity, erectile difficulty and urinary incontinence.

Only one study has concentrated on BT as a single treatment modality [32]. In patients given a permanent transperineal radioactive implant, only a minority was psychologically impaired six months later. The pity is omission of a baseline measure, longer follow-up and controls. More work is needed on the psychological impact of BT, an increasingly common treatment for localised disease.

Two studies examined the association between RT and fatigue. As is common in psychiatric samples, fatigue could be due to depression. Monga et al. [33] examined this question in men with localised cancer using a repeated measures design. Fatigue did increase during RT but this was not associated with depression changes. A link however was found between fatigue and physical well-being. In another investigation [34], the team sought to determine the cause of fatigue and linked it to diminished neuromuscular efficiency, not psychological factors.

These studies of a prominent clinical feature like fatigue are worthwhile, particularly the effort to tease out links with psychological factors; useful psychological therapeutic implications are likely to emerge.

Hormone therapy (HT) and psychological adjustment (see Table 6)

Table 6 Hormone therapy (HT) and psychological adjustment

Suppressing androgens is an accepted intervention in metastatic PCA but its role in less advanced disease is clouded given the complex issues involved – the goal of extending survival, occurrence of side-effects and impact on the psychological state.

The most noteworthy investigation of six identified is Herr and O'Sullivan's [35] follow-up of men with locally advanced PCA. While not a RCT, the men were offered orchidectomy, pharmacological androgen suppression or observation. Well-selected measures were administered at baseline, and at six and 12 months. Men receiving HT experienced significantly more distress than did those under observation. The finding raises the question of how to balance HT's adverse psychological effects with the potential benefit of extended life.

Herr et al. [36] also compared QOL in HT-treated and untreated men but on a sample diagnosed with metastatic PCA. Again, men were offered HT or observation and followed up for six months. The untreated group had better psychological adjustment than the HT-treated.

A similar study involved patients treated with orchidectomy or combined HT [37]. Measures covering fatigue and emotional and social functioning were completed at several points over 12 months. Although pain and urological symptoms improved, emotional and social functioning did not. This study stands out methodologically by virtue of obtaining both self-report and physician-based ratings. However, concordance was surprisingly poor.

In another study on men with metastatic PCA [38], but with the advantage of a comparison group, patients were randomised to one of three forms of HT or observation and completed psychological measures at baseline and six months later. As in Herr et al. [36] adjustment was similar across all groups, despite impaired sexual functioning in the hormone conditions. As part of their work, Green et al. [39] obtained patients' verbal comments and found substantial individual differences on such themes as health beliefs and coping. A detailed analysis revealed complex responses. Adjustment was worse in those with physical comorbidity, suggesting the relevance of health status in ascertaining adjustment associated with different treatments. HT enhanced or decreased adjustment. The position seems more intricate than conventional analyses reveal, and raises the question of whether broad brush-stroke patterns of psychological responses may mislead.

Another approach is to focus on a single psychological aspect. Stone et al. [9] considered fatigue. After three months of HT, fatigue had increased markedly but this was not related to adjustment but to diminished muscle function. Pirl et al. [40] selected depression in a heterogenous PCA group and found its prevalence eight times the national male rate. This was not associated with disease progression or use of chemotherapy but to a prior history of depression. Thus, history of disordered mood is a possible risk factor for depressive reactions in this group.

Comparing different treatments and psychological adjustment (see Table 7)

Table 7 Comparing different cancer treatments and psychological adjustment

A typical study is by Lee et al. [41], in which patients with localised PCA were treated with surgery, RT or BT. They completed psychological measures before treatment and at several points during the next year. Poor adjustment was notable in the first month in the surgery and BT groups but not the RT group. At 12 months the difference had evaporated, with adjustment reverting to pre-therapy levels. The authors posited that patients should be counselled about differential treatment effects. We are less convinced, given that these were remarkably similar after three months. The non-randomised design, a serious limitation, precludes setting guidelines.

Few teams have adopted a prospective design. In a RCT comparing steroids and HT in men with metastatic PCA, Fossa et al. [42] examined psychological effects over six months. Patients on steroids were better off than their HT counterparts. However, patients dropped out in both groups because of deterioration in health and that the psychological difference was observed particularly from the third to the 12th week. We may also note the authors' corollary that steroids should be considered as a first choice in hormone-resistant PCA but a brief comparison period because of attrition suggests a more tentative conclusion.

The prospective study by da Silva [43] compared adjustment after orchidectomy or HT over 12 months. However, attrition proved such a problem that comparisons were not feasible.

Steginga et al. [44] assessed psychological function before treatment – either RT, RP or watchful waiting – at two and 12 months later in men with localized PCA. The three groups showed improved adjustment over time but were similar at all three points. The relevance of obtaining baseline data is shown by the findings that QOL was similar to that found in the community.

Other studies in this area are cross-sectional, retrospective and lack baseline measures. The value of any findings is thus diminished. Eton et al. [45], for instance, compared adjustment to (non-randomised) RT, external beam RT and BT in men with localised PCA. Given the limited design, the three groups, not surprisingly, were similar in role function, perception of health and emotional well-being. A similar picture was found by Litwin et al. [46] in their comparison of RP, RT, observation alone and control.

A comparison of adjustment in watchful waiting, HT, RT and RP by Fossa et al. [47] (see their 2001 prospective study above) was also cross-sectional and retrospective. Despite physical morbidity in many patients, adjustment was rated as good. As the authors surmised, men with PCA seem to accept physical problems as the price for therapy that might cure.

Lilleby et al. [48] measured, cross-sectionally, adjustment of RT and RP a year following treatment. Desirable features were sizable samples and a control group (a watch and wait condition). Results were similar in both groups, with less than one in 10 reporting poor adjustment.

In another adequately sized sample, this time of advanced PCA patients, HT and orchidectomy were compared [49]. Adjustment improved after six months in the medical but not surgical group. Given that this was not a RCT and that follow-up was brief, proper comparisons are difficult, but results suggest surgical HT may be less appropriate than medical HT.

Two studies have examined the effects of treatments on sexual functioning. Bokhour et al. [50] formed focus groups of men who had undergone RT or BT for non-metastatic PCA sharing experiences of impotence. Although this method serves as a fertile source of qualitative material, pitfalls abound. Noteworthy here was sampling: men were recruited from medical centres but how they were selected is not stated, and only a third of 130 invitees participated. Nevertheless, the approach highlights the value of eliciting narratives, which may complement quantitative data. Mixed methods of data collection warrant serious consideration.

The importance of prospective studies incorporating baseline measures is vividly illustrated by Van Andel et al. [51]. They compared baseline profiles of men who received surgery or external beam RT. The latter reported worse functioning in physical, role, sexual and social domains. While these differences might have been attributable to treatment, it is critical to measure baseline psychological adjustment so that any pre-treatment discrepancies can be controlled.

The effects of psychological interventions on adjustment (see Additional file 1)

Given a diagnosis of life-threatening cancer like PCA, the question arises as to whether interventions can be devised to help patients (and possibly partners) with such sequelae as existential concerns, poor coping and psychiatric morbidity. Considering the accomplishments in breast cancer [52], the dearth of studies in PCA is striking; only a few researchers have mounted an intervention to deal with psychological needs.

Educational programs are the most common but limited in what they set out to achieve. In an RCT, Helgesen et al. [53] compared "treatment as usual" with a program in which a trained nurse contacted the patient every six months over three years (the patient could also initiate contact) to explore general health and PCA-related difficulties. There were no differences at baseline or follow-up. The authors concluded that a nurse-based follow-up is cost-effective and "safe", i.e. nothing serious is missed. Little can be assumed about the psychological dimension, given the focus on nurse as "doctor surrogate".

Another nurse-based study concentrated on preparing patients for RT [54]. Routine nursing was offered as a controlled condition, consisting of a brief "tutorial" on the nature and side-effects of the treatment. The intervention was delivered at four points: pre-RT, during the first and last weeks of therapy, and one month following termination. Again, the goal was to inform the men about RT's nature and side-effects, but in much more detail, and the program also embraced psychological issues. The researchers only found less disruption of customary life activities in the intervention group compared with the controls.

Hack et al. [55] audiotaped the patient-oncologist consultation and compared its effects to a control group. Six weeks later, patients who received audiotapes were better able to recall information and were more satisfied with the level of communication. This is not an elaborate initiative but probably contributes to the doctor-patient alliance. Whether psychological well-being is affected remains unclear. A single tape might not exert much influence but, as part of a psycho-educational program, it might help as a means to empower the patient.

Another way to enhance doctor-patient communication is through printed information. Templeton and Coates [56] conducted an RCT in which men with PCA receiving hormone therapy were randomly assigned to receive an education package or to a control condition. Significant differences were found on knowledge about PCA and its treatment and on QOL but the groups used similar coping strategies. The absence of disease staging and only a one-month follow-up are notable limitations.

Lepore and colleagues [57] examined group-based education in men with localized PCA, comparing its effects with a controlled condition and a more ambitious intervention – an educational group plus discussion. The interventions were held weekly for six weeks. At one-year follow-up, the "education plus discussion" patients were less bothered by sexual difficulties and more likely to be in steady employment than the other patients. The authors' speculation that the opportunity to discuss personal problems confers extra benefits is intuitively appealing.

Mishel et al. [58] examined the moderating effects of variables such as race, education and number of sources of information on two psycho-educational interventions for localised PCA patients. Those with less education benefited by increasing their knowledge; men with more sources of information also did better. These results support implementing interventions that tailor content and teaching methods to specific needs.

Only two teams [59, 60] have tested more substantial interventions, based on cognitive behaviour therapy (CBT) strategies. In the former RCT [59], less than half the patients were satisfied or reported any benefit after an average 3.6 sessions. The study is replete with limitations: only one in four invitees participated; data are presented for treated patients but not for controls; treatment ranged from one to 24 sessions, despite a set limit of eight; no baseline assessments were obtained; and the sample was heterogeneous (localised and metastatic disease).

The RCT by Petersson et al. [60] was substantially better in design and execution. Treatment over eight weekly sessions (and a booster) contained education, CBT and relaxation. Psychological distress three months after commencement improved compared to controls but this was confined to copers who actively sought information in contrast to those who avoided doing so, identifying a moderator of benefits. A snag is the range of therapeutic components; the question remains as to which lead to change.

Much has been written about support groups (SGs) in cancer, particularly of the breast, but PCA does not feature particularly. We have found only four papers, and none of them illuminating. The differential gender attention could relate to the possibility that men are less inclined to share their health concerns with others.

Krizek et al. [61] asked men with PCA about their experience of, and attitudes to, SGs. Only one in eight had attended one or more meetings, but those who had, did so an average 10 times, and valued sharing concerns. In-depth enquiry of reasons for not attending might have proved informative.

It would be worthwhile repeating such a study with a representative sample and a more comprehensive form of enquiry. Poole et al. [62] have accomplished this to a degree. They administered questionnaires to PCA patients recruited though SGs and radiotherapy/oncology clinics. Not unexpectedly, both SG members and non-participants identified a spouse/partner as most helpful in providing emotional and practical support. The former relied on SG members for information, the latter on doctors. Possibly because of the prominent role of spouse/partner, no differences emerged between the two groups regarding coping and adjustment. SGs seem limited in their effects, although they do need to be evaluated in a RCT.

Gregoire et al. [63] did not apply such a design in their study of men (as well as "some" relatives) recruited to participate in 10 weekly sessions led by a nurse and a psychologist, which concentrated on information about PCA, its effects and its treatments. Men who attended regularly rated the experience highly since it helped them to cope more effectively. The authors pointed to evidence for the utility of SGs despite conceding the dubious representativeness of the sample and lack of baseline data.

Only one study has examined the value of an actual SG intervention [64]. The researchers hypothesised that men with PCA, facing the prospect of RT who received information about the treatment, would cope more effectively than controls. Taped material was given to men at four points, each containing accounts by former patients of their RT experience. One outcome variable differentiated intervention from control groups – the former were far less disrupted in their customary recreational activities during and after treatment. The groups, however, were similar in terms of negative mood, this probably attributable to normal baseline levels. A similar study with more emotionally distressed patients is clearly indicated.

Johnson [65] has extended this work by looking at the role of optimism-pessimism. In a similar RCT, information exerted a positive effect in pessimistic patients. Again, intervention led to less disruption of recreational activities, this time in both optimistic and pessimistic men.

An interesting variation of the SG emerges from the pilot work of Weber et al. [66] who recruited 10 long-term (three plus years) PCA "survivors" of RP to serve as partners over eight weekly sessions to men who had undergone surgery for PCA. The latter were randomised to this intervention or to a control condition. Self-efficacy increased in the peer-supported men but not in the controls but benefit in terms of depression was limited. Although the small sample precluded adequate statistical treatment the self-help rationale is sound and may suit men who are hesitant about participating in a group.

In arguing the need for an RCT to test the efficacy of SGs, we are not suggesting neglect of other methods. Qualitative research, for instance, enables us to learn about group therapeutic factors involved. A good example is Arrington's [67] participant observation. Interested in how the men dealt with sexuality, he observed a disproportionate emphasis on performance but was cognisant of three limitations: excluding the perspective of spouses/partners, thereby neglecting relational dynamics; using a restricted sample of men from a retirement community; and the fluctuating nature of group membership. Notwithstanding, the approach complements traditional methods and further qualitatively-based research is worthwhile.

The quality of research on psychological interventions varies. Considerably more sophisticated therapies are needed through which psychological distress can be addressed. While education and problem solving have a place, RCTs directed to such features as depression, anxiety, marital strain and poor coping are needed.


Although this review reveals many gaps in knowledge, embryonic patterns are emerging. Cross-sectional studies comparing men with PCA and controls suggest few differences in levels of psychological distress. But we must appreciate that PCA patients constitute a heterogeneous group and that adjustment is better in those with localised disease compared to those with advanced forms.

Longitudinal studies do not suggest that adjustment worsens over time. However, early signs of distress, particularly depression and anxiety, indicate a poorer psychological prognosis. Coping that involves interpersonal awareness and expression of emotions is linked to better adjustment. By contrast, a sense of helplessness correlates with low self-esteem and depression.

Implications for clinicians

Clinicians would be advantaged if able to detect distress in their patient and in the couple, as well as to identify those at risk, and in knowing about programs that alleviate psychological complications. Little knowledge has accumulated thus far. We can only rely on low-level evidence such as that emerging from observational studies.

Men with PCA do not appear to experience marked impairment of adjustment; the rate is much less than that of women with breast cancer. As is well established in men's health research, low rates of morbidity may reflect a belief that admitting to personal difficulties and the need for help is a "sign of weakness" [68]. Moreover, questionnaire-based designs may fail to penetrate these "avoidant" responses.

An alternative to the questionnaire is the focus group. Qualitative data may be as valuable as quantitative data. Thus, in the study by Bokhour [50], participants felt able to talk about sexual impotence and related concerns. The typical limitation is the poor generalization of findings.

Given the low rate of psychological morbidity, the clinician's ability to identify predictors would at least enable them to monitor "at risk patients". At this stage, however, statements about predictors cannot be made. Longitudinal studies with adequate methodology are essential to address this question and these are rare.

We had anticipated differential effects on adjustment of the medical treatments offered to men with PCA but outcomes tend to be uniform. We should remember, however, that they tend to start with low levels of distress. A corollary is the role of psychological outcomes in decision-making about treatment. If it were the case, for instance, that a specific treatment affected mood adversely, clinicians could point this out in the consent process.

One study alerts us to the dangers of possible artefacts in calculating mean scores for presumed homogeneous populations. Green [38] found a mixed pattern when examining the psychological effects of hormone therapy – one subgroup improved, another deteriorated. Moderating factors are elusive but their likely relevance makes it imperative to identify them.

Even if we could identify those at risk, the literature does not guide the clinician to interventions of proven value. This aspect is the most scanty of all those researched. Educational strategies and support groups have negligible influence. The role of psychotherapy is unclear, since trials are rare, and limited methodologically. For the moment, the clinician must resort to ideographic appraisal regarding the sort of help a patient requires.

Implications for researchers

The implications that follow mirror the limitations noted throughout the review, namely: sampling, design, controls, outcome measures and statistical methods.

The most striking feature is the need for studies of adequate standard. Consider sampling: larger, more representative and well-described samples are required, e.g., age, socio-economic status, ethnicity, education, stage of cancer and treatment received. A key strategy is multi-site recruitment. Even then, a sample with enough power takes time to generate; selection criteria guarantee that.

Aspects of design also need attention. Cross-sectional "snapshots" are of limited value in that they fail to tell us how long symptoms persist and who is vulnerable to enduring maladjustment. A snapshot at the point of diagnosis is bound to be influenced by reactions on learning one has a life-threatening illness. Similarly, assessment following one or another treatment will be affected by the nature of that treatment. Only prospective, longitudinal, repeated measures designs can illuminate the patient's journey and identify risk factors.

Control groups are crucial even though they present difficulties, especially for an observational study. In any treatment study, a control condition is essential if results are to be taken seriously. Recruitment might be less thorny than for prevalence studies; the ethical dilemma of not providing treatment is not insurmountable since there is no current psychological standard intervention for men with PCA.

A close examination of psychometric issues is beyond the scope of this paper but valid and reliable measures to describe the psychological features of PCA patients and to use as outcome criteria are required. The variegated and, in some cases, home-baked measures encountered has precluded confident interpretation of the results emerging from their use. Researchers need to concentrate on well-established instruments, like the Beck Depression and the Brief Symptom Inventories, and evaluate them in a concerted way.

Qualitative work is a valuable complement to quantitative research. There is scope to encompass thematic analyses in future research, especially with the advent of sophisticated software to examine patients' narratives.

Statistical methods have improved substantially in recent years and need to be applied in future work. Consider two of many possible illustrations: sampling and differential outcome. In allocating men with PCA to different arms of a RCT, it will be vital to do so with rigor, including the need for stratification. We will need to examine a range of sub-groups such as the varied outcomes in different clinical groups of patients, e.g., on a spectrum of severity of psychological distress.


Psychological adjustment to PCA has attracted growing interest of investigators but the yield over the past decade has, in contrast to the picture in breast cancer, been meagre, both in terms of the number of studies carried out and their methodological rigour. If future research is to prove more useful, the bar will need to be raised. Fortunately, several leads have emerged; the time has arrived to make the most of them.


  1. Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC: Quality of life of patients with prostate cancer and their spouses. Cancer. 1994, 73: 2791-2802. 10.1002/1097-0142(19940601)73:11<2791::AID-CNCR2820731123>3.0.CO;2-9.

    Article  CAS  PubMed  Google Scholar 

  2. Eton DT, Lepore SJ: Prostate cancer and health-related quality of life: A review of the literature. Psycho-Oncology. 2002, 11: 307-326. 10.1002/pon.572.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Kiss A, Meryn S: Effect of sex and gender on psychosocial aspects of prostate and breast cancer. British Medical Journal. 2001, 323: 1055-8. 10.1136/bmj.323.7320.1055.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Roesch SC, Adams L, Hines A, Palmores A, Vyas P, Tran G, Peksa S, Vaughan A: Coping with prostate cancer: A meta-analytic review. Journal of Behavioural Medicine. 2005, 28: 281-293. 10.1007/s10865-005-4664-z.

    Article  Google Scholar 

  5. Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachi I: The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer. 2002, 94: 862-871. 10.1002/cncr.10248.

    Article  PubMed  Google Scholar 

  6. Clark JA, Inui TS, Silliman RA, Bokhour BG, Krasnow SH, Robinson RA, Spaulding M, Talcott JA: Patients' perceptions of quality of life after treatment for early prostate cancer. Journal of Clinical Oncology. 2003, 21: 3777-3784. 10.1200/JCO.2003.02.115.

    Article  PubMed  Google Scholar 

  7. Helgason AR, Adolfsson J, Dickman PW, Fredrikson M, Arver S, Steineck G: Waning sexual function: The most important disease-specific distress for patients with prostate cancer. British Journal of Cancer. 1996, 73: 1417-1421.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Heim HM, Oei TP: Comparison of prostate cancer patients with and without pain. Pain. 1993, 53: 159-162. 10.1016/0304-3959(93)90075-Z.

    Article  CAS  PubMed  Google Scholar 

  9. Stone P, Richards M, A'Hern R, Hardy J: A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology. 2000, 11: 561-567. 10.1023/A:1008331230608.

    Article  CAS  PubMed  Google Scholar 

  10. Balderson N, Towell T: The prevalence and predictors of psychological distress in men with prostate cancer who are seeking support. British Journal of Health Psychology. 2003, 8: 125-134. 10.1348/135910703321649114.

    Article  PubMed  Google Scholar 

  11. Curran D, Fossa SD, Aaronson NK, Kiebert G, Keuppens E, Hall RR: Baseline quality of life of patients with advanced prostate cancer. European Journal of Cancer. 1997, 33: 1809-1814. 10.1016/S0959-8049(97)00187-1.

    Article  CAS  PubMed  Google Scholar 

  12. Schag CAC, Ganz PA, Wing DS, Sim MS, et al: Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 1994, 3: 127-141.

    Article  CAS  Google Scholar 

  13. McBride CM, Clipp E, Peterson BL, Lipkus IM, Demark-Wahnefried W: Psychological impact of diagnosis and risk reduction among cancer survivors. Psycho Oncology. 2000, 9: 418-427. 10.1002/1099-1611(200009/10)9:5<418::AID-PON474>3.0.CO;2-E.

    Article  CAS  PubMed  Google Scholar 

  14. Horowitz M, Wilner N, Alvarez W: Impact of event scale: a measure of subjective stress. Psychosomatic Medicine. 1979, 41: 209-218.

    Article  CAS  PubMed  Google Scholar 

  15. Penedo FJ, Daha JR, Gonzalez JS, Molton I, Carrer CS, Antoni MH, Roos BS: Perceived stress management skill mediates the relationship between optimism and positive mood following radical prostatectomy. Health Psychology. 2003, 22: 220-222. 10.1037/0278-6133.22.2.220.

    Article  PubMed  Google Scholar 

  16. Nordin K, Berglund G, Glimelius B, Sjoeden PO: Predicting anxiety and depression among cancer patients: A clinical model. European Journal of Cancer. 2001, 37: 376-384. 10.1016/S0959-8049(00)00398-1.

    Article  CAS  PubMed  Google Scholar 

  17. Visser A, van Andel G: Psychosocial and educational aspects in prostate cancer patients. Patient Education & Counseling. 2003, 49: 203-206. 10.1016/S0738-3991(03)00024-7.

    Article  Google Scholar 

  18. Helgeson VS, Lepore SJ: Men's adjustment to prostate cancer: The role of agency and unmitigated agency. Sex Roles. 1997, 37: 251-267. 10.1023/A:1025651912128.

    Article  Google Scholar 

  19. Lepore SJ, Helgeson VS: Social constraints, instrusive thoughts, and mental health after prostate cancer. Journal of Social and Clinical Psychology. 1998, 17: 89-106.

    Article  Google Scholar 

  20. Zakowski SG, Harris C, Krueger N, Lambmeier KK, Garrett S, Flanigan R, Johnson P: Social barriers to emotional expression and their relations to distress in male and female cancer patients. British Journal of Health Psychology. 2003, 8: 271-286. 10.1348/135910703322370851.

    Article  PubMed  Google Scholar 

  21. Watson M, Greer S, Young J, Inayat Q, Burges C, Robertson B: Development of a questionnaire measure of adjustment to cancer: The MAC scale. Psychological Medicine. 1988, 18: 203-209.

    Article  CAS  PubMed  Google Scholar 

  22. Bjork JP, Hopp DP, Jones LW: Prostate cancer and emotional functioning: Effects of mental adjustment, optimism, and appraisal. Journal of Psychosocial Oncology. 1999, 17: 71-85. 10.1300/J077v17n01_05.

    Article  Google Scholar 

  23. Pietroff PK, Parekh DJ, Smith JA, Shyr Y, Cookson MS: Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. Journal of Urology. 2001, 166: 2286-2290. 10.1016/S0022-5347(05)65552-8.

    Article  Google Scholar 

  24. Rossetti SR, Terrone C: Quality of life in prostate cancer patients. European Urology. 1996, 30: 44-48.

    PubMed  Google Scholar 

  25. Heathcote PS, Mactaggart PN, Boston RJ, James AN, Thompson LC, Nicole DL: Health-related quality of life in Australian men remaining disease free after radical prostatectomy. Medical Journal of Australia. 1998, 168: 483-486.

    CAS  PubMed  Google Scholar 

  26. Meyer JP, Gillan DA, Lockyer R, MacDonagh RP: The effect of erectile dysfunction on the quality of life of men after radical prostatectomy. British Journal of Urology. 2003, 92: 929-931.

    Article  Google Scholar 

  27. Ficarra V, Righetti R, D'Amico A, Pilloni S, Balzarro M, Schiavone D, Malossini G, Mobilio G: General state of health and psychological well-being in patients after surgery for urological malignant neoplasms. Urologica Internationalis. 2000, 65: 130-134. 10.1159/000064857.

    Article  CAS  Google Scholar 

  28. Rondorf-Klym LM, Colling J: Quality of life after radical prostatectomy. Oncology Nursing Forum. 2003, 30: E24-32.

    Article  PubMed  Google Scholar 

  29. Caffo O, Fellin G, Graffer U, Luciani L: Assessment of quality of life after radical radiotherapy for prostate cancer. British Journal of Urology. 1996, 78: 557-563.

    Article  CAS  PubMed  Google Scholar 

  30. Joly F, Brune D, Couette JE, Lesaunier F, Heron JF, Peny J, Henry Amar M: Health-related quality of life and sequelae in patients with brachytherapy and external beam irradiation for localized prostate cancer. Annals of Oncology. 1998, 9: 751-757. 10.1023/A:1008276632623.

    Article  CAS  PubMed  Google Scholar 

  31. Arterbery VE, Frazier A, Dalmia P, Siefer J, Lutz M, Porter A: Quality of life after permanent prostate implant. Seminars in Surgical Oncology. 1997, 13: 461-464. 10.1002/(SICI)1098-2388(199711/12)13:6<461::AID-SSU11>3.0.CO;2-W.

    Article  CAS  PubMed  Google Scholar 

  32. Monga U, Kerrigan AJ, Thornby J, Monga TN: Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiation Oncology Investigations. 1999, 7: 178-185. 10.1002/(SICI)1520-6823(1999)7:3<178::AID-ROI7>3.0.CO;2-0.

    Article  CAS  PubMed  Google Scholar 

  33. Monga U, Jaweed M, Kerrigan AJ, Lawhon L, Johnson JE, Vallbona C, Monga TN: Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy. Archives of Physical Medicine and Rehabilitation. 1997, 78: 961-966. 10.1016/S0003-9993(97)90058-7.

    Article  CAS  PubMed  Google Scholar 

  34. Herr HW, O'Sullivan M: Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. Journal of Urology. 2000, 163: 1743-1746. 10.1016/S0022-5347(05)67533-7.

    Article  CAS  PubMed  Google Scholar 

  35. Herr HW, Kornblith AB, Ofman US: A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer. 1993, 71: 1143-1150. 10.1002/1097-0142(19930201)71:3+<1143::AID-CNCR2820711437>3.0.CO;2-I.

    Article  CAS  PubMed  Google Scholar 

  36. da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, Whelan P, Hetherington J, Fava C, Richards B, Robinson MRG: The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853. European Journal of Cancer. 1996, 32A (1): 72-77. 10.1016/0959-8049(95)00402-5.

    Article  CAS  PubMed  Google Scholar 

  37. Green HJ, Pakenham KI, Headley BC, Gardiner RA: Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring. Psycho-Oncology. 2002, 11: 401-414. 10.1002/pon.599.

    Article  PubMed  Google Scholar 

  38. Green H: The context of adjustment: Qualitative reports from Australian men being treated for non-localized prostate cancer. Clinical Psychologist. 2003, 7: 81-92. 10.1080/13284200410001707533.

    Article  Google Scholar 

  39. Pirl WF, Siegel GI, Goode MJ, Smith MR: Depression in men receiving androgen deprivation therapy for prostate cancer: A pilot study. Psycho-Oncology. 2002, 11: 518-523. 10.1002/pon.592.

    Article  PubMed  Google Scholar 

  40. Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL: A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 2001, 51: 614-623. 10.1016/S0360-3016(01)01707-2.

    Article  CAS  PubMed  Google Scholar 

  41. Fossa SD, Slee PH, Brausi M, Horenblas S, Hall RR, Hetherington JW, Aaronson NK, de Prijck L, Collette L: Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: A phase 3 study of the European Organization for Research and Treatment of Cancer genitourinary group. Journal of Clinical Oncology. 2001, 19: 62-71.

    CAS  PubMed  Google Scholar 

  42. da Silva FC: Quality of life in prostatic cancer patients. Cancer. 1993, 72: 3803-3806. 10.1002/1097-0142(19931215)72:12+<3803::AID-CNCR2820721708>3.0.CO;2-U.

    Article  CAS  PubMed  Google Scholar 

  43. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P: Prospective study of men's psychological and decision-related adjustment after treatment for localised prostate cancer. Urology. 2004, 63: 751-6. 10.1016/j.urology.2003.11.017.

    Article  PubMed  Google Scholar 

  44. Eton DT, Lepore SJ, Helgeson VS: Early quality of life in patients with localized prostate carcinoma: An examination of treatment-related, demographic, and psychosocial factors. Cancer. 2001, 92: 1451-1459. 10.1002/1097-0142(20010915)92:6<1451::AID-CNCR1469>3.0.CO;2-R.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995, 273: 129-135. 10.1001/jama.273.2.129.

    Article  CAS  PubMed  Google Scholar 

  46. Fossa SD, Woehre H, Kurth KH, Hetherington JW, Bakke H, Rustad DA, Skanvik R: Influence of urological morbidity on quality of life in patients with prostate cancer. European Urology. 1997, 31: 3-8.

    PubMed  Google Scholar 

  47. Lilleby W, Fossa SD, Waehre HR, Olsen DR: Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. International Journal of Radiation Oncology, Biology, Physics. 1999, 43: 735-743. 10.1016/S0360-3016(98)00475-1.

    Article  CAS  PubMed  Google Scholar 

  48. Cassileth BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ, Kennealey GT: Quality of life and psychosocial status in Stage D prostate cancer. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 1992, 1: 323-330.

    Article  CAS  Google Scholar 

  49. Bokhour BG, Clark JA, Inui TS, Silliman RA, Talcott JA: Sexuality after treatment for early prostate cancer: Exploring the meanings of "erectile dysfunction.". Journal of General Internal Medicine. 2001, 16: 649-655. 10.1111/j.1525-1497.2001.00832.x.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Van Andel G, Visser A, Hulshof M, Horenblass , Kurth K: Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy. British Journal of Urology International. 2003, 92: 217-22.

    Article  CAS  Google Scholar 

  51. Classen C, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson R, Kraemer H, Spiegel D: Supportive-expressive group therapy and distress in patients with metastatic breast cancer. Archives of General Psychiatry. 2001, 58: 494-501. 10.1001/archpsyc.58.5.494.

    Article  CAS  PubMed  Google Scholar 

  52. Helgesen F, Andersson SO, Gustafsson O, Varenhorst E, Goben B, Carnock S, Sehlstedt LPCLH, Johansson JE: Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: A randomized study. Scandinavian Journal of Urology and Nephrology. 2000, 34: 55-61. 10.1080/003655900750016904.

    Article  CAS  PubMed  Google Scholar 

  53. Johnson JE, Fieler VK, Wlasowicz GS, Mitchell ML, Jones LS: The effects of nursing care guided by self-regulation theory on coping with radiation therapy. Oncology Nursing Forum. 1997, 24: 1041-1050.

    CAS  PubMed  Google Scholar 

  54. Hack TF, Pickles T, Bultz BD, Degner LF, Katz A, Davison BJ: Feasibility of an audiotape intervention for patients with cancer: A multicenter, randomized, controlled pilot study. Journal of Psychosocial Oncology. 1999, 17: 1-15. 10.1300/J077v17n02_01.

    Article  Google Scholar 

  55. Templeton H, Coates V: Evaluation of an evidence-based education package for men with prostate cancer on hormonal manipulation therapy. Patient Education and Counseling. 2004, 55: 55-61. 10.1016/j.pec.2003.07.005.

    Article  PubMed  Google Scholar 

  56. Lepore S, Helgeson V, Eton D, Schulz R: Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychology. 2003, 22: 443-52. 10.1037/0278-6133.22.5.443.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Mishel MH, Germino BB, Belyea M, Stewart JL, Bailey DE, Mohler J, Robertson C: Moderators of an uncertainty management intervention for men with localised prostate cancer. Nursing Research. 2003, 52: 89-97. 10.1097/00006199-200303000-00005.

    Article  PubMed  Google Scholar 

  58. Hellbom M, Brandberg Y, Glimelius B, Sjoeden PO: Individual psychological support for cancer patients: Utilisation and patient satisfaction. Patient Education and Counseling. 1998, 34: 247-256. 10.1016/S0738-3991(98)00033-0.

    Article  CAS  PubMed  Google Scholar 

  59. Petersson LM, Nordin K, Glimelius B, Brekkan E, Sjoden PO, Berglund G: Differential effects of cancer rehabilitation depending on diagnosis and patients' cognitive coping style. Psychosomatic Medicine. 2002, 64: 971-980. 10.1097/01.PSY.0000028825.64279.F2.

    PubMed  Google Scholar 

  60. Krizek C, Roberts C, Ragan R, Ferrara JJ, Lord B: Gender and cancer support group participation. Cancer Practice. 1999, 7: 86-92. 10.1046/j.1523-5394.1999.07206.x.

    Article  CAS  PubMed  Google Scholar 

  61. Poole G, Poon C, Achille M, White K, Franz N, Jittler S, Watt K, Cox DN, Doll R: Social support for patients with prostate cancer: The effects of support groups. Journal of Psychosocial Oncology. 2001, 19: 1-16. 10.1300/J077v19n02_01.

    Article  Google Scholar 

  62. Gregoire I, Kalogeropoulos D, Corcos J: The effectiveness of a professionally led support group for men with prostate cancer. Urological Nursing. 1997, 17: 58-66.

    CAS  Google Scholar 

  63. Johnson JE, Lauver DR, Nail LM: Process of coping with radiation therapy. Journal of Consulting & Clinical Psychology. 1989, 57: 358-364. 10.1037/0022-006X.57.3.358.

    Article  CAS  Google Scholar 

  64. Johnson JE: Coping with radiation therapy: Optimism and the effect of preparatory interventions. Research in Nursing & Health. 1996, 19: 3-12. 10.1002/(SICI)1098-240X(199602)19:1<3::AID-NUR1>3.0.CO;2-S.

    Article  CAS  Google Scholar 

  65. Weber BA, Roberts B, Resnick M, Deimling G, Zauszniewski J, Musil C, Yarandi H: The effect of dyadic intervention on self-efficacy, social support, and depression for men with prostate cancer. Psycho-Oncology. 2004, 13: 47-60. 10.1002/pon.718.

    Article  PubMed  Google Scholar 

  66. Arrington MI: Sexuality, society, and senior citizens: An analysis of sex talk among prostate cancer support group members. Sexuality & Culture. 2000, 4: 45-74.

    Article  Google Scholar 

  67. Brownhill S, Wilhelm K, Barclay L, Schmied V: "Big build': hidden depression in men. Australian and New Zealand Journal of Psychiatry. 2005, 39: 921-931. 10.1111/j.1440-1614.2005.01665.x.

    PubMed  Google Scholar 

Download references


This research was supported by a grant from the National Health and Medical Research Council of Australia.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Sidney Bloch.

Electronic supplementary material

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Bloch, S., Love, A., Macvean, M. et al. Psychological adjustment of men with prostate cancer: a review of the literature. BioPsychoSocial Med 1, 2 (2007).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: